Global projections indicate that between 20% and 90% of current coastal wetland areas may be lost due to sea-level rise (SLR), depending on the severity of the scenario. Warming, acidification and other global change stressors such as eutrophication also show negative impacts on coastal wetlands. Such a scenario poses a dramatic threat to biodiversity, particularly in deltas and estuaries, which are vital for the conservation of coastal species and ecosystem functions. This paper summarizes the main impacts of climate change on coastal wetland biodiversity, with focus on vegetation, birds and fish. Management options to cope with climate change impacts are also summarized. Many coastal wetlands are already undergoing degradation or disappearing due to the combined impacts of climate change and other global drivers, including SLR, subsidence, sediment deficits, coastal erosion, and salt stress. Coastal squeeze, the restriction of natural habitat migration due to human infrastructure and natural constraints, also threatens these ecosystems. Enhancing the resilience of coastal wetlands involves improving hydrological connectivity, increasing sediment inputs, boosting wetland plant productivity, and allowing space for natural coastal processes. However, these efforts are highly dependent on active conservation, management and restoration policies. The future of coastal wetland biodiversity will vary significantly based on the climate scenarios that unfold, and the policies implemented. Highlights Coastal wetland biodiversity has severely declined due to habitat loss and other aspects of global change. Remaining wetlands are endangered by climate change impacts such as sea level rise.Salt marshes are the most endangered coastal wetlands in Europe, along with their associated flora and fauna. The Mediterranean coast may lose up to 90% of those habitats by the end of the 21st century due to sea level rise.Boosting coastal wetland resilience is critical to avoid biodiversity loss. To do this requires increasing the pace and scale of coastal wetland restoration, and enhancing the ecogeomorphic dynamics through the increase of hydrological connectivity and the supply of sediments to the coasts.
Background/objectivesHuman milk (HM) is the gold standard for neonatal nutrition, providing essential macronutrients and bioactive compounds that promote immune and gastrointestinal development. Among these components, HM-derived extracellular vesicles (HMEVs) are emerging as key mediators of intestinal maturation and protection against necrotizing enterocolitis (NEC). HMEVs carry miRNAs, proteins, and bioactive lipids that resist digestion and modulate critical signaling pathways in the immature gut, making them particularly relevant for preterm infants.MethodsThis study describes the development and adaptation of a robust, scalable workflow for isolating HMEVs from donor HM for potential use as a nutritional supplement. An initial laboratory-scale isolation protocol was successfully scaled up to a sterile, clinically compatible process. Key modifications included increasing ultracentrifugation speed, eliminating filtration, and replacing phosphate-buffered saline (PBS) with a resuspension medium suitable for nutritional applications.ResultsThe scaled procedure increased the processed milk volume from 25 mL to 63 mL while reducing the HMEVs isolation time from 14 hs to 7.7 h. Tunable Resistive Pulse Sensing (TRPS) and ExoViewⓇ analysis showed that these modifications led to an approximate 2-fold increase in EV recovery following centrifugation speed optimization. In addition, omission of filtration yielded a 4.3-fold increase in HMEV recovery. The isolated HMEVs exhibited high purity, reaching up to 3.98 × 1013 particles/g protein. The final product was resuspended in 5% glucose solution, chosen for its physiological compatibility, favorable osmolarity (< 380 mOsmol/kg), and ability to preserve EV stability for up to 30 days at −80 °C. The HMEV preparation was produced under sterile conditions, and endotoxin testing returned negative results.ConclusionsThis optimized and scalable method enables the safe and efficient isolation of HMEVs for use in neonatal nutritional supplements. These findings establish methodological groundwork for future translational studies of milk-derived EVs aimed at supporting intestinal development and immune protection, and potentially reducing the risk of NEC in preterm infants.
The building sector accounts for over one-third of global energy consumption and approximately 26
Accurate detection of micro- and macrocancer lesions remains a critical challenge in histopathology, as conventional hematoxylin and eosin staining requires labor-intensive analysis and is limited in sensitivity toward microscopic foci. Here, we present an artificial intelligence (AI)-assisted workflow integrating Fourier transform infrared (FT-IR) hyperspectral imaging with chemometric modeling for enhanced cancer screening in lung tissues. Using a focal-plane array (128 × 128 pixels with a pixel projection of 5.5 μm × 5.5 μm), hyperspectral maps were generated, enabling biochemical characterization of distinct morphological structures, including bronchial and vascular walls, parenchyma, and neoplastic regions. Histopathological annotations were employed to construct calibration data sets for noncancerous tissues, microcancer lesions, and macrocancer lesions. Discriminant analysis revealed high predictive accuracy across validation strategies, with CORRS-CV (δ = 5) outperforming conventional k-fold and image-based approaches (AUROC = 0.94, accuracy = 97%, and specificity = 98%). This robust performance reflects reduced cross-validation bias and improved generalizability of predictive models. Importantly, FT-IR imaging enabled the detection of both macro- and microlesions consistent with histological references, while also revealing spectral similarities in vascular walls that occasionally led to false-positive predictions. Together, these findings demonstrated that AI-assisted FT-IR chemometrics offers the rapid, label-free, and spatially resolved detection of cancer lesions, complementing standard histopathology by improving sensitivity to microscopic disease and supporting stratification of tumor progression.
Engineered carbon-based nanocarriers provide a versatile platform for probing drug delivery-induced molecular responses in complex cellular models. Here, we report 2-acrylamido-2-methylpropanesulfonic acid (AMPS)-derived carbon dots (CDs) as vehicles for riluzole delivery in three-dimensional (3D) glioblastoma (GBM) spheroids, with 3D astrocyte spheroids employed as nontumoral control samples. Synchrotron radiation-based Fourier transform infrared (SR-FTIR) spectro-microscopy was used to map subcellular biochemical responses, enabling label-free, high-resolution chemical imaging within intact 3D architectures. Multivariate analysis of SR-FTIR data revealed GBM-specific biomolecular alterations following treatment, including DNA conformational changes, lipid peroxidation, and protein secondary structure remodeling, whereas astrocyte spheroids exhibited minimal spectral perturbations, indicating a selective molecular response. Supervised classification using orthogonal partial least-squares-discriminant analysis (OPLS-DA) with constrained repeated random sampling cross-validation reliably differentiated treated and control spheroids, achieving high pixel-level classification accuracy and spatial consistency. These results demonstrate the capability of SR-FTIR microspectroscopy and imaging combined with multivariate analysis to resolve treatment-induced molecular responses in 3D tumor models while discriminating nontumoral controls. This integrated nanomaterial-spectroscopy approach provides a robust, data-driven framework for analytically evaluating nanocarrier-drug-cell interactions in complex biological systems.